-+ 0.00%
-+ 0.00%
-+ 0.00%

iBio amends 8-K to correct Series G warrants expiration date to May 20, 2026

PUBT·04/17/2026 21:14:19
Listen to the news
iBio amends 8-K to correct Series G warrants expiration date to May 20, 2026
  • iBio filed Form 8-K/A to correct typographical error in prior 8-K on expiration date for Series G Warrants.
  • Series G Warrants now set to expire 5:00 p.m. New York time on May 20, 2026.
  • Outstanding Series G Warrants totaled 11,065,000 shares as of April 17, 2026.
  • Common stock outstanding was 36,143,561 shares as of April 17, 2026.
  • Company issued pre-funded warrants for up to 13,790,000 shares following original 8-K, tied to Series G Warrant exercises.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iBio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-044969), on April 17, 2026, and is solely responsible for the information contained therein.